Pfizer Current Affairs, GK & News
Conditional market approval for Covaxin, Covishield
The Drug regulator in India has granted conditional market approval for the COVISHIELD and COVAXIN vaccines. This means that the private hospitals shall administer the vaccines. However, the vaccines will not be available in retail medical stores. What is conditional market authorisation? The Serum Institute vaccine COVISHELD and Bharat Biotech’s COVAXIN were administered in the ..
Month: Current Affairs - January, 2022
Category: Economy & Banking Current Affairs - 2022
Topics: AstraZeneca • Bharat Biotech • conditional market authorisation • COVAXIN • COVID 19 pandemic • Covishield • Drugs and Cosmetics Act 1940 • Emergency Use Authorisation • European Union (EU) • mRNA vaccine • Pfizer • Serum Institute of India (SII) • USFDA
Pfizer starts study of mRNA Flu vaccine
On September 28, 2021, Pfizer Inc. announced that the first batch of participants have been dosed with the single dose quadrivalent mRNA vaccine in a Phase 1 clinical trial. Highlights Under the phase 1 trial, safety, tolerability, and immunogenicity of the single dose quadrivalent mRNA vaccine will be studied against influenza in healthy adults. mRNA ..
Month: Current Affairs - September, 2021
Category: Science & Technology Current Affairs
Topics: COVID-19 • Genetic Sequencing • mRNA Flu vaccine • mRNA technology • mRNA-based influenza vaccine • Pfizer
US announces 500 Million Vaccine doses to Poor Countries
United States President Joe Biden has announced to donate 500 million doses of Pfizer COVID-19 vaccine to poorest countries across world to end the pandemic as soon as possible. Key Points This donation is a bold move which showed, US recognises its responsibility towards world as well as its citizens. US will provide these half ..
Month: Current Affairs - June, 2021
Category: International / World Current Affairs
Topics: ACT accelerator • COVAX • COVAX Facility • COVID-19 • GAVI • Global Alliance for Vaccines and Immunization (GAVI) • Pfizer
Canada approves Mixing & Matching Covid-19 vaccine brands
Canada has recommended “mixing and matching” of AstraZeneca, Pfizer and Moderna Covid-19 vaccines. NACI Guidelines National Advisory Committee on Immunization (NACI) had issued guidelines for provinces and territories on mixing and matching second doses of Covid-19 vaccines. It has advised Canadians to combine either “AstraZeneca-Oxford, Pfizer-BioNTech or Moderna shots” interchangeably for specific situations. NACI recommended ..
Month: Current Affairs - June, 2021
Category: International / World Current Affairs
Topics: AstraZeneca • COVID-19 vaccine • Mixing & Matching Covid-19 vaccine brands • Moderna vaccines • National Advisory Committee on Immunization (NACI) • Pfizer • Pfizer-BioNTech
WHO clears Chinese Vaccine Sinovac for global use
World Health Organisation (WHO) has given approval for global use of covid-19 Vaccine by Sinovac Biotech Ltd. Of China. Highlights WHO recommended its use for people above 18 years. Two-dose will be scheduled for it, with a gap of two to four weeks between shots. Sinopharm Group Co. had secured WHO’s approval for emergency use ..
Month: Current Affairs - June, 2021
Category: International / World Current Affairs
Topics: AstraZeneca • Chinese Vaccine • CoronaVac • Johnson & Johnson • Moderna Inc • Pfizer • Pfizer-BioNTech
India to start tests on mixed vaccines
According to Dr N K Arora, chairman of Covid-19 working group under National Technical Advisory Group on Immunization (NTAGI), India may soon start testing feasibility of mixing two different doses of Covid vaccines to check whether it helps in boosting immune response against virus or not. Highlights While responding to the question “if a person ..
Month: Current Affairs - June, 2021
Category: Science & Technology Current Affairs
Topics: AstraZeneca • COVID-19 • Mixed Vaccine • National Immunization Technical Advisory Group (NITAG) • Pfizer • Vaccine Shortage